Nand Multispeciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 1.50 M
as on 17-07-2024
- Company Age 7 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.74 Cr
as on 17-07-2024
- Revenue 180.97%
(FY 2022)
- Profit 450.91%
(FY 2022)
- Ebitda 160.65%
(FY 2022)
- Net Worth 4961.26%
(FY 2022)
- Total Assets -12.41%
(FY 2022)
About Nand Multispeciality Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹6.74 Cr.
Ankit Jhaveri, Niraj Thakershi, and Yayati Nayankumar serve as directors at the Company.
- CIN/LLPIN
U74999GJ2017PTC100180
- Company No.
100180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nand Multispeciality Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Jhaveri  | Director | 18-Dec-2017 | Current |
| Niraj Thakershi | Director | 18-Dec-2017 | Current |
| Yayati Nayankumar | Director | 18-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Nand Multispeciality Hospitals.
Nand Multispeciality Hospitals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 180.97% increase. The company also saw a substantial improvement in profitability, with a 450.91% increase in profit. The company's net worth Soared by an impressive increase of 4961.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nand Multispeciality Hospitals?
In 2022, Nand Multispeciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 May 2022 | ₹5.90 Cr | Open |
The City Co-Operative Bank Limited Creation Date: 15 Mar 2022 | ₹1.00 M | Open |
The City Co-Operative Bank Limited Creation Date: 04 Dec 2020 | ₹0.73 M | Open |
How Many Employees Work at Nand Multispeciality Hospitals?
Nand Multispeciality Hospitals has a workforce of 16 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nand Multispeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nand Multispeciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
